Indefinite Delivery Contract SPE2DR25D2214

The federal contract IDV award SPE2DR25D2214 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $999,999,999 and runs through December 2036, providing worldwide pharmaceutical and medical supply support to the Department of Defense, U.S. Coast Guard, and other designated government agencies and healthcare programs.

The contract was awarded without any set-aside requirements, allowing for open competition. It covers a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The contract serves as a primary vehicle for DLA Troop Support Medical to efficiently procure these essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The solicitation for this contract, expected to be issued in March 2024, will seek multiple regional primary suppliers and a single backup supplier to ensure resiliency and access to vital pharmaceuticals during contingency or natural disaster situations.